Clinical trials in Feltre

Clinical research in Feltre includes studies focused on advanced non-small-cell lung cancer, with attention on improving outcomes for people starting treatment for this aggressive disease. These trials are exploring whether combining targeted cancer therapies can offer better disease control and longer survival.

• Testing new treatment approaches for advanced non-small-cell lung cancer
• Evaluating whether combination therapy can improve overall survival
• Supporting better first-line care for patients with PD-L1 high metastatic NSCLC

The work reflects a broader effort to refine cancer treatment strategies and make therapies more effective for patients in routine care.

Another active area of research in Feltre is chronic kidney disease, where trials are studying ways to slow progression and reduce serious heart-related complications. The goal is to strengthen heart and kidney protection through better treatment combinations.

• Studying new options for people with chronic kidney disease
• Assessing whether treatment can prevent worsening kidney function
• Looking at reductions in hospitalisation for heart failure and cardiovascular death

These studies aim to improve long-term management for patients living with kidney disease and related cardiovascular risks.